HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/6/R1085    most recent 00726.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Luodonpää, M. Articles by Ruskoaho, H. Search for Related Content PubMed PubMed Citation Articles by Luodonpää, M. Articles by Ruskoaho, H.

NEUROHUMORAL CONTROL OF CIRCULATION AND HYPERTENSION

Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats

Departments of ¹Pharmacology and Toxicology, and ²PhysiologyBiocenter Oulu, University of Oulu, 90014 Oulu, Finland

Submitted 22 December 2003 ; accepted in final form 26 January 2004

We examined whether adrenomedullin, a vasoactive peptide expressed in the heart, modulates the increase in blood pressure, changes in systolic and diastolic function, and left ventricular hypertrophy produced by long-term administration of ANG II or norepinephrine in rats. Subcutaneous administration of adrenomedullin (1.5 µg·kg^–1·h^–1) for 1 wk inhibited the ANG II-induced (33.3 µg·kg^–1·h^–1 sc) increase in mean arterial pressure by 67% (P < 0.001) but had no effect of norepinephrine-induced (300 µg·kg^–1·h^–1 sc) hypertension. Adrenomedullin enhanced the ANG II-induced improvement in systolic function, resulting in a further 9% increase (P < 0.01) in the left ventricular ejection fraction and 19% increase (P < 0.05) in the left ventricular fractional shortening measured by echocardiography, meanwhile norepinephrine-induced changes in systolic function were remained unaffected. Adrenomedullin had no effect on ANG II- or norepinephrine-induced left ventricular hypertrophy or expression of hypertrophy-associated genes, including contractile protein and natriuretic peptide genes. The present study shows that adrenomedullin selectively suppressed the increase in blood pressure and augmented the improvement of systolic function induced by ANG II. Because adrenomedullin had no effects on ANG II- and norepinephrine-induced left ventricular hypertrophy, circulating adrenomedullin appears to act mainly as a regulator of vascular tone and cardiac function.

catecholamines; hypertrophy; ventricular function